Endothelium-dependent and -independent mechanisms of vasorelaxation by corticotropin-releasing factor in pregnant rat uterine artery

Journal of Pharmacology and Experimental Therapeutics

Volumn 288, Issue 2, 1999, Pages 407-413

  Jain, Venu ^a   Vedernikov, Yurij P ^a   Saade, George R ^a   Chwalisz, Kristof ^b   Garfield, Robert E ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b BAYER PHARMA AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

6 ANILINO 5,8 QUINOLINEQUINONE; 9 (TETRAHYDRO 2 FURYL)ADENINE; CALCIUM CHANNEL BLOCKING AGENT; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR[9-41]; CYCLIC AMP; CYCLIC GMP; CYTOCHROME P450 INHIBITOR; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; GLIBENCLAMIDE; GUANYLATE CYCLASE INHIBITOR; INDOMETACIN; MICONAZOLE; N(G) NITROARGININE METHYL ESTER; NITRENDIPINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NORADRENALIN; POTASSIUM; POTASSIUM CHANNEL BLOCKING AGENT; PROSTACYCLIN; PROSTAGLANDIN SYNTHASE INHIBITOR; TETRABUTYLAMMONIUM; THIOPENTAL; VASODILATOR AGENT;

ANIMAL TISSUE; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; RAT; UTERINE ARTERY;

ANIMALS; ARTERIES; CORTICOTROPIN-RELEASING HORMONE; ENDOTHELIUM, VASCULAR; FEMALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; PREGNANCY; PREGNANCY, ANIMAL; RATS; RATS, SPRAGUE-DAWLEY; UTERUS; VASODILATION;

EID: 0033064449     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Barany M (1996) Biochemistry of Smooth Muscle Contraction, Academic Press, San Diego.
2. Battaglia G, Webster EL and De Souza EB (1987) Characterization of corticotropin-releasing factor receptor-mediated adenylate cyclase activity in the rat central nervous system. Synapse 1:572-581.
3. Brayden JE and Nelson MT (1992) Regulation of arterial tone by activation of calcium-dependent potassium channels. Science 256:532-535.
4. Brown MR, Fisher LA, Spiess J, Rivier, J, Rivier C and Vale W (1982) Comparison of biologic actions of corticotropin-releasing factor and sauvagine. Regul Pept 4:107-114.
5. Campbell EA, Linton EA, Wolfe CD, Scraggs PR, Jones MT and Lowry PJ (1987) Plasma corticotropin-releasing hormone concentrations during pregnancy and parturition. J Clin Endocrinol Metab 64:1054-1059.
6. Campbell WB, Gebremedhin D, Pratt PF and Harder DR (1996) Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factor. Circ Res 78:415-423.
7. Clifton VL, Read MA, Leitch IM, Giles WB, Boura ALA, Robinson PJ and Smith R (1995) Corticotropin-releasing hormone-induced vasodilatation in the human fetal-placental circulation: Involvement of the nitric oxide-cyclic guanosine 3′,5′-monophosphate-mediated pathway. J Clin Endocrinol Metab 80:2888-2893.
8. 125I]Tyr-corticotropin-releasing factor to rabbit aorta is reduced by removal of the endothelium. Eur J Pharmacol 135:111-112.
9. Fisher LA, Jessen G and Brown MR (1983) Corticotropin-releasing factor (CRF): Mechanisms to elevate arterial pressure and heart rate. Regal Pept 5:153-161.
10. Furchgott RF (1983) Role of endothelium in responses of vascular smooth muscle. Cirr Res 53:557-573.
11. Furchgott RF (1993) Introduction to EDRF research. J Cardiovasc Pharmacol 22: S1-S2.
12. Gardiner SM, Compton AM and Bennet T (1988) Regional haemodynamic effects of depressor neuropeptides in conscious, unrestrained, Long Evans and Brattleboro rats. Br J Pharmacol 95:197-208.
13. Grigoriadis DE, Lovenberg TW, Chalmers DT, Liaw C and De Souza EB (1996) Characterization of corticotropin-releasing factor receptor subtypes. Ann N Y Acad Sci 780:60-80.
14. Holzmann S (1982) Endothelium-induced relaxation by acetylcholine associated with larger rises in cyclic GMP in coronary arterial strips. J Cyclic Nucleotide Res 8:409-419.
15. Jain V, Vedernikov YP, Saade GR, Chwalisz K and Garfield RE (1997) The relaxation responses to corticotropin-releasing factor in rat aorta are endothelium dependent and gestationally regulated. Am J Obstet Gynecol 176:234-240.
16. Jain V, Vederniko, YP, Saade GR, Chwalisz K and Garfield RE (1998) In vivo effects of corticotropin-releasing factor in pregnant rats. Am J Obstet Gynecol 178:186-191.
17. Kawada T, Ishibashi T, Sasage H, Kato K and Imai S (1994) Modification by LY 83583 and methylene blue of relaxation induced by nitric oxide, glyceryl trinitrate, sodium nitroprusside and atriopeptin in aortae of the rat, guinea pig and rabbit. Gen Pharmacol 25:1361-1371.
18. 2+ channels in human epidermoid A-431 cells. Eur J Pharmacol 267:135-142.
19. Lei S, Richter R, Bienert M and Mulvany MJ (1993) Relaxing actions of corticotropin-releasing factor on rat resistance arteries. Br J Pharmacol 108:941-947.
20. 22536. Comp Biochem Physiol 99:209-211.
21. Lischke V, Busse R and Hecker M (1995) Selective inhibition by barbiturates of the synthesis of endothelium-derived hyperpolarizing factor in the rabbit carotid artery. Br J Pharmacol 115:969-974.
22. Little PJ, Campbell JH, Skews H and Bobik A (1984) Mechanism of isoprenaline induced desensitization of rabbit aortic smooth muscle beta-adrenoceptor responses. Clin Exp Pharmacol Physiol 11:503-511.
23. Luckhoff A and Busse R (1986) Increased free calcium in endothelial cells under stimulation with adenine nucleotides. J Cell Physiol 126:414-420.
24. Moncada S and Vane JR (1979) Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin. Pharmacol Rev 30:293-331.
25. Mulvany MJ and Halpern W (1977) Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 41:19-26
26. Osol G, Cipolla M and Knutson S (1989) A new method for mechanically denuding the endothelium of small (50-150 microns) arteries with a human hair. Blood Vessels 26:320-324.
27. Petraglia F, Florio P, Gallo R, Simoncini T, Saviozzi M, Di Blasio AM, Vaughan J and Vale W (1996) Human placenta and fetal membranes express human urocortin mRNA and peptide. J Clin Endocrinol Metab 81:3807-3810.
28. G-nitro-L-arginine methyl ester (L-NAME): Requirement for bioactivation to the free acid, N-nitro-L-arginine. Br J Pharmacol 118:1433-1440.
29. Polk DH, Ervin MG, Padbury JF, Lam RW, Reviczky AL and Fisher DA (1987) Epidermal growth factor acts as a corticotropin-releasing factor in chronically catheterized fetal lambs. J Clin Invest 79:984-988.
30. Poston L, McCarthy AL and Ritter JM (1995) Control of vascular resistance in the maternal and feto-placental arterial beds. Pharmacol Ther 65:215-239.
31. Riley SC, Walton JC, Herlick JM and Challis JR (1991) The localization and distribution of corticotropin-releasing hormone in the human placenta and fetal membranes throughout gestation. J Clin Endocrinol Metab 72:1001-1007.
32. Rivier C, Brownstein M, Spiess J, Rivier J and Vale W (1982) In vivo corticotropin-releasing factor-induced secretion of adrenocorticotropin, beta-endorphin and corticosterone. Endocrinology 110:272-278.
33. Rohde E, Furkert J, Fechner K, Beyermann M, Mulvany MJ, Richter RM, Denef C, Bienert M and Berger H (1996) Corticotropin-releasing hormone (CRH) receptors in the mesenteric small arteries of rats resemble the (2)-subtype. Biochem Pharmacol 52:829-833.
34. Rubanyi GM (1993) The role of endothelium in cardiovascular homeostasis and diseases. J Cardiovasc Pharmacol 22:S1-S14.
35. Sibai BM (1996) Hypertension in Pregnancy, in Obstetrics: Normal and Problem Pregnancies (Gabbe S, Niebyl JR and Simpson JL eds) pp 935-996, Churchill Livingstone, New York.
36. Singer HA and Peach MJ (1982) Calcium- and endothelial-mediated vascular smooth muscle relaxation in rabbit aorta. Hypertension 4:19-25.
37. Vanhoutte PM (1996) Endothelium-Derived Hyperpolarizing Factor, Harwood Academic Publishers, Amsterdam.
38. Vaughan J, Donaldson C, Bittencourt J, Perrin MH, Lewis K, Sutton S, Chan R, Turnbull AV, Lovejoy D and Rivier C (1995) Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature (London) 378:287-292.
39. ++ exchange in the release of endothelium-derived relaxing factor. J Pharmacol Exp Ther 235:644-650.
40. Wu KK (1995) Inducible cyclooxygenase and nitric oxide synthase. Adv Pharmacol 33:179-207.